New Discovery To Aid In Diagnosis And Treatment Of Kidney Disease

ScienceDaily — Researchers from Boston University School of Medicine (BUSM) in collaboration with scientists at the University of Louisville and the University of Nice Sophia Antipolis in France, have identified the target antigen PLA2R in patients with idiopathic membranous nephropathy (kidney disease), which has implications for the diagnosis and treatment of this disease. These findings appear in the July 2 issue of the New England Journal of Medicine.
Please click here for more information

Please visit LifeAlysis for current renal news and information

Advertisements

Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp295- Pauly, et al.-These results indicate that NHD and DTX survival is comparable, and suggest that this intensive dialysis modality may be a bridge to transplantation or even a suitable alternative in the absence of LTX in the current era of growing transplant waiting lists and organ shortage.
Please click here for more information

Please visit LifeAlysis for current news and information

Kidney removed by ‘scarless’ surgery

BBC News-During the surgery a small 10mm incision was made in the crevice of Estelle’s belly button and a “single access port” inserted through which instruments and a small camera were fed. 
Please click here for more information

Please visit LifeAlysis for current renal news and information

Plasma Exchange Aids Kidney Transplant Patients

Please click here for more information

Please visit LifeAlysis for current renal news and information

Spiritual Beliefs and Quality of Life of Dialysis Patients

This study evaluated the correlations between spiritual beliefs and health-related quality of life (HRQOL) of hemodialysis (HD) patients in Taiwan. Participants had to complete two questionnaires: the 36-item Short Form Health Survey Questionnaire and the Royal Free Interview for Spiritual and Religious Beliefs.

Please click here for more information

Please visit LifeAlysis for current renal news and information

Medication changes based on echocardiography in dialysis patients

Hemodialysis International-Kidney/Disease Outcome Quality Initiative (K/DOQI) guidelines recommend baseline echocardiography at the initiation of dialysis and every 3 years thereafter in patients for early detection of cardiac disease to optimize medical therapy. Because dialysis patients are at increased cardiovascular risk and thus most are already on cardioprotective medications, we hypothesize that serial screening echocardiography will not alter cardioprotective medications in dialysis patients.
Click here for more information

Please visit LifeAlysis for current renal news and information

Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients

Hemodialysis International-Khedr E et al. – Patients treated with rHuEPO showed less insulin resistance compared with patients not treated with rHuEPO in diabetic and nondiabetic patients and, duration of erythropoietin treatment is negatively correlated with insulin levels and insulin resistance in HD patients.
Please click here for more information

Please visit LifeAlysis for current renal news and information